Video

Addressing the Uncertainty Surrounding Biosimilars

Author(s):

Randi Hernandez, MS, Associate Editor/Online

Steven Lucio of Novation discusses why now is the time for pharmacists to educate themselves about biosimilars and the complexities surrounding biologic manufacturing.

Steven Lucio of Novation discusses why now is the time for pharmacists to educate themselves about biosimilars and the complexities surrounding biologic manufacturing.

This video was shot at the 2013 Academy of Managed Care Pharmacy Nexus Meeting in San Antonio, Texas.

Related Videos
Woman experiencing pain related to recurrent pericarditis -- Image credit: Art_Photo | stock.adobe.com
Pharmacist assisting a patient with pericarditis -- Image credit: Yuri Arcurs/peopleimages.com | stock.adobe.com
Related Content
Blood plasma as a hope for treatment of coronavirus infection. Syringe with blood plasma in a hand in a blue medical glove against the sky. Platelet-Rich plasma preparation.
February 21st 2025

Administering Plasma Therapy Requires Pharmacist Collaboration With Specialty Care Team

Luke Halpern, Assistant Editor
Pharmacy Focus: Oncology Edition - Discussing Increasing Rates of Lung Cancer in Young Adults and Emerging Precision Treatments
November 25th 2024

Pharmacy Focus: Oncology Edition - Discussing Increasing Rates of Lung Cancer in Young Adults and Emerging Precision Treatments

ACTIVATE-Kids Study Demonstrates Efficacy of Oral Therapy for Children With PK Deficiency
February 20th 2025

ACTIVATE-Kids Study Demonstrates Efficacy of Oral Therapy for Children With PK Deficiency

Aislinn Antrim, Managing Editor
Pharmacy Focus: Oncology Edition- Exploring Pelareorep: A Novel Immunotherapy for Advanced Breast Cancer
October 28th 2024

Pharmacy Focus: Oncology Edition- Exploring Pelareorep: A Novel Immunotherapy for Advanced Breast Cancer

Pharmaceutical Market Research, drug development, clinical trials, market size, competitive analysis, regulatory compliance, FDA approval, 4K, HD - Image credit: Aryan | stock.adobe.com
February 18th 2025

Condition Watch: Biosimilars

Ashley Gallagher, Editor
Amgen Prolia Denosumab for injection in pre-filled syringe with protective cap. Monoclonal antibody used to treat bone loss in women post menopause
February 17th 2025

FDA Approves Biosimilar Denosumab-dssb to Treat Osteoporosis-, Cancer-Related Bone Loss

Luke Halpern, Assistant Editor